For both studies, standardized frontal and lateral view preoperative and postoperative images of 20 patients who completed staged FFS (combinations of frontal sinus wall setback, supraorbital recontouring, mandibular angle reduction, genioplasty, upper lip shortening, septorhinoplasty, tracheolaryngeoplasty) were used; in addition, 10 male and 10 female unoperated control patients were included. (1) For the first study, the images were analyzed by 4 public neural networks trained to identify gender. Preliminary results led us to (2) a second study, using an online crowdsourcing platform. Respondents identified the gender of the same images, randomized, with a confidence rating (1: not confident; 10: highly confident). Age and smoking status were recorded as distractants. All results were recorded and analyzed for statistical significance.
PURPOSE: Autologous cartilage (AC) grafting is considered the gold standard for rhinoplasty for cleft nasal deformity as it is associated with a low risk of infection and extrusion. However, harvesting AC such as rib involves donor site morbidity and increased time under anesthesia. As irradiated homologous costal cartilage (IHCCs) grafts may have a similar complication profile as AC but without the donor site morbidity, they may be an effective alternative in patients with cleft nasal deformity.
METHODS:
A retrospective study was performed on pediatric and adult patients with a history of cleft lip who underwent rhinoplasty for cleft nasal deformity at Johns Hopkins Hospital between 2009 and 2018. Patients were excluded if their rhinoplasty did not involve placement of an AC or IHCC graft.
RESULTS:
A total of 165 cleft rhinoplasties (age 2-72 years, 73%; age <18 years, 52% female) were performed, using a mean of 3 cartilage grafts. Thirty percentage of these procedures were revision surgeries. Mean follow-up time was 407 days. Ninety-six (58%) procedures used IHCC, with the remaining utilizing AC. Complications resulted from 18 (11%) procedures: 7 (10%) involving AC and 11 (12%) involving IHCC grafts. Six of 7 AC complications (86%) required operative intervention, compared to 7 out of 11 (64%) for IHCC. The most common complications for IHCC and AC, respectively, were infection (n = 5) and collapse (n = 2). One AC procedure resulted in hypertrophic donor site scarring, 1 graft resorbed, and 1 warped; 1 IHCC graft extruded, none resorbed, and 2 warped. There was no difference between groups regarding complication rate or complications requiring operative intervention (P = 0.3, P = 0.5).
CONCLUSIONS: IHCC grafts are equally safe and effective as AC for use in rhinoplasty for cleft nasal deformity. These grafts are readily available and eliminate donor site morbidity.
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BACKGROUND: Idiopathic intracranial hypertension (IIH) is a disease process attributed to increased intracranial pressure (ICP) that often presents with headaches, visual deterioration, and papilledema. Severe cases are often refractory to medical treatment, lumbar punctures, and cerebrospinal fluid shunts. Internal cranial expansion (ICE)
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is a relatively novel technique that involves removing and shaving down the skull's inner calvarial table and cancellous bone to increase intracranial volume and reduce ICP. Previous studies have shown success in pediatric patients. The present study describes the effectiveness of ICE in adult patients with IIH.
METHODS:
A retrospective review was conducted of 9 patients from the ages of 18-61 years who underwent ICE for the treatment of IIH. Preoperative and postoperative clinical parameters including patient symptoms, presence of papilledema, and available ICP or cerebrospinal fluid opening pressures were compared. Procedural details and complications were noted. Intracranial volume increases were calculated using available pre-and postoperative computerized tomography scans.
RESULTS:
Mean follow-up for the 9 patients in this series was 8 months. Technically successful ICE was performed in all patients within the cohort without any surgical complications. At the time of last follow-up, 4 (44%) of 9 patients were either symptomatically improved or asymptomatic. Three (33%) of 9 patients with headache had a reduction in or complete resolution of this symptom. Papilledema was resolved in all patients (4 of 4) with this sign. Postoperative intracranial volume expansion ranged between 6.9% and 18%.
CONCLUSIONS: ICE is a safe procedure that can provide symptomatic improvement for some adult patients and thus has a role in treatment of refractory IIH outside of the pediatric population. This surgery expands the intracranial volume and thus promotes ICP normalization, which may lead to the reduction or complete resolution of the signs and symptoms of IIH. ICE may be used as part of a multidisciplinary management approach in the treatment of refractory IIH.
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BACKGROUND: Inherited and acquired hypercoagulable conditions affect 15% of the population, and these conditions are often considered a relative contraindication to microvascular surgery. Anticoagulation protocols may be used to improve outcomes of microvascular surgery. The effects of anticoagulation protocols on success rates in the hypercoagulable head and neck population and complications related to these protocols have not been well described.
METHODS:
A retrospective review was conducted of subjects who underwent microvascular head and neck reconstruction at a tertiary medical center over a 6-year period. Hypercoagulable subjects were defined as having an inherited coagulopathy or preoperative thrombotic event. Perioperatively, subjects were treated with individualized anticoagulation protocols. Outcomes studied were microvascular flap complications (thrombotic event or flap loss) and anticoagulation-related complications (flap or donor site hematoma). Multivariate analysis was used to compare outcomes.
RESULTS:
A total of 137 head and neck microvascular reconstructions were performed during the study period. A preoperative thrombotic event had occurred in 23 of 24 subjects; 18 of 23 subjects (78.3%) had a history of deep venous thrombosis, 5 (21.7%) of PE, and 5 (21.7%) of spontaneous thrombotic stroke before 50 years old. Five subjects (20.8%) were diagnosed with an inherited or acquired thrombophilic disorder preoperatively. All subjects were treated with aspirin intraoperatively and daily postoperatively (n = 26; 92.9%), unless contraindicated by allergy. Subjects were stratified based on preoperative and intraoperative risk factors to receive either group 1 (low risk): prophylactic-dosing subcutaneous anticoagulation (n = 13; 46.4%); group 2 (medium risk): prophylactic-dosing continuous heparin infusion at 500 units/h (n = 8; 28.6%); or, group 3 (high risk): therapeutic anticoagulation/continuous PTT goal-based heparin infusion (n = 5; 17.9%). An inferior vena cava (IVC) filter was utilized in 12 reconstructions and was placed preoperatively in 9 subjects (32.1%) and postoperatively in 3 subjects (10.7%). All flaps were successful; however, 2 of 28 flaps (7.1%) were salvaged by operative revision from postoperative thrombotic events, 1 arterial and 1 venous, occurring on postoperative day 1. Focal necrosis requiring surgical excision and advancement occurred in 2 of 28 flaps (7.1%). A hematoma occurred at the site of flap inset in 3 of 28 reconstructions (10.7%) and at 2 donor sites (7.1%). Multivariate analysis of anticoagulation protocol did not demonstrate a statistical effect on flap complication rate or salvage. However, there was a statistically significant higher rate of both flap and donor site hematomas in group 3 with the use of therapeutic anticoagulation (P = 0.04). Subjects who had an IVC filter had a statistically higher rate of hematomas (P = 0.002) and trended toward increased flap complications (P = 0.06).
CONCLUSIONS:
In our experience, the choice of anticoagulation protocol in hypercoagulable subjects does not affect reconstructive outcomes. However, we found that
